E-LIB Suche - Ergebnisse für: Gillison, Maura L

1

Outcomes in biomarker-selected subgroups from the KESTREL s..:

Seiwert, Tanguy Y. ; Wildsmith, Sophie ; Fayette, Jérôme...
Cancer Immunology, Immunotherapy. 73 (2024) 4 - p. , 2024

Link: https://doi.org/10.1007/..

2

Surrogate endpoints in clinical trials of p16-positive squa..:

Gharzai, Laila A ; Morris, Emily ; Suresh, Krithika...
The Lancet Oncology. 25 (2024) 3 - p. 366-375 , 2024

Link: https://doi.org/10.1016/..

3

Elucidating immune-related gene transcriptional programs vi..:

He, Shan ; Gubin, Matthew M. ; Rafei, Hind...
iScience. , 2024

Link: https://doi.org/10.1016/..

4

Intratumoral Heterogeneity and Clonal Evolution Induced by ..:

Akagi, Keiko ; Symer, David E. ; Mahmoud, Medhat...
Cancer Discovery. 13 (2023) 4 - p. 910-927 , 2023

Link: https://doi.org/10.1158/..

5

Upper age limits for US male human papillomavirus vaccinati..:

Landy, Rebecca ; Haber, Gregory ; Graubard, Barry I...
JNCI: Journal of the National Cancer Institute. 115 (2023) 4 - p. 429-436 , 2023

Link: https://doi.org/10.1093/..

6

Noninvasive genomic profiling of somatic mutations in oral ..:

Xi, Yuanxin ; Negrao, Marcelo V. ; Akagi, Keiko...
Oral Oncology. 140 (2023) - p. 106372 , 2023

Link: https://doi.org/10.1016/..

7

Safety of Nivolumab Added to Chemoradiation Therapy Platfor..:

Gillison, Maura L. ; Ferris, Robert L. ; Harris, Jonathan...
International Journal of Radiation Oncology*Biology*Physics. 115 (2023) 4 - p. 847-860 , 2023

Link: https://doi.org/10.1016/..

8

Representative oral microbiome data for the US population: ..:

Vogtmann, Emily ; Chaturvedi, Anil K ; Blaser, Martin J...
The Lancet Microbe. 4 (2023) 2 - p. e60-e61 , 2023

Link: https://doi.org/10.1016/..

9

Incidence and Clearance of Anal Human Papillomavirus Infect..:

Wei, Feixue ; Goodman, Marc T ; Xia, Ningshao...
Clinical Infectious Diseases. 76 (2022) 3 - p. e692-e701 , 2022

Link: https://doi.org/10.1093/..

10

Long-term Outcomes with Nivolumab as First-line Treatment i..:

Gillison, Maura L ; Blumenschein Jr, George ; Fayette, Jerome...
The Oncologist. 27 (2022) 2 - p. e194-e198 , 2022

Link: https://doi.org/10.1093/..

11

Risk factors for head and neck cancer in more and less deve..:

Goyal, Neerav ; Hennessy, Max ; Lehman, Erik...
Oral Diseases. 29 (2022) 4 - p. 1565-1578 , 2022

Link: https://doi.org/10.1111/..

12

Proton Beam Therapy for Head and Neck Carcinoma of Unknown ..:

Sherry, Alexander D. ; Pasalic, Dario ; Gunn, G. Brandon...
International Journal of Particle Therapy. 8 (2021) 1 - p. 234-247 , 2021

Link: https://doi.org/10.14338..

13

Proton Therapy for Head and Neck Cancer: A 12-Year, Single-..:

Gunn, G. Brandon ; Garden, Adam S. ; Ye, Rong...
International Journal of Particle Therapy. 8 (2021) 1 - p. 108-118 , 2021

Link: https://doi.org/10.14338..

14

Cytotoxic and targeted systemic therapy in patients with ad..:

Tam, Samantha ; Gajera, Mona ; Luo, Xiaoning...
Head & Neck. 43 (2021) 5 - p. 1592-1603 , 2021

Link: https://doi.org/10.1002/..

15

Risk stratification after recurrence of human papillomaviru..:

Bigelow, Elaine O. ; Harris, Jonathan ; Fakhry, Carole...
Head & Neck. 44 (2021) 1 - p. 158-167 , 2021

Link: https://doi.org/10.1002/..